Bafazol IC
BafazolWhen stress takes over, you feel almost on the verge of a breakdown. It seems that everything is against you: it is not possible to correctly assess the significance of events, obsessive anxiety, anxiety and fear appear, problems with sleep arise, and efficiency and performance decrease. All these factors weaken us. But despite all the worries and stresses, we must be strong.
Indications for use (instruction): Bafazol IC
The drug is indicated for use in adults for the treatment of anxiety states generalized anxiety disorders, neurasthenia, adaptation disorders, and patients with various somatic diseases (bronchial asthma, irritable bowel syndrome, systemic lupus erythematosus, coronary heart disease, arterial hypertension, arrhythmias), dermatological, oncological and other diseases.
The drug is used to treat sleep disorders associated with anxiety; neurocirculatory dystonia, premenstrual syndrome, and alcohol withdrawal syndrome, to relieve the withdrawal syndrome when quitting smoking.
How to use
Apply internally after meals. The optimal single dose is 10 mg, and the daily dose is 30 mg, which should be divided into 3 doses during the day. The duration of the treatment course is 2–4 weeks. If necessary, according to the doctor's recommendation, the daily dose of the drug can be increased to 60 mg, and the duration of treatment - up to 3 months. The use of the medicinal product by children under the age of 18 is contraindicated.
Contraindications
Individual intolerance to any components of the medicinal product. Galactose intolerance, lactase deficiency, or glucose-galactose malabsorption syndrome. The period of pregnancy and breastfeeding. Children age up to 18 years.
Patients with established intolerance to some sugars should consult a doctor before using the medicine.
Due to the lactose content, the drug should not be taken by patients with rare hereditary galactose intolerance, lactase deficiency, or glucose-galactose malabsorption syndrome.
Use of the drug during pregnancy is contraindicated. Breastfeeding should also be stopped during the period of use of the medicinal product.
The drug does not hurt the ability to drive vehicles and the ability to perform potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.
Composition
Active substance: fabomotizole; 1 tablet contains fabomotizole dihydrochloride 10 mg;
Excipients: potato starch, microcrystalline cellulose, StarLac® (lactose monohydrate, corn starch), talc, silicon dioxide colloidal anhydrous, magnesium stearate.
Release form
20 tablets in a blister; 2 or 3 blisters in a pack.
Manufacturer
"INTERKHIM" Limited Liability Company.
Address: Ukraine, 65025, Odesa, 21st km. 40-A, Starokyivska road.
Registration certificate
UA/18761/01/01 dated 06/02/2021 order No. 1081
Official web site
Bafazol IC
This section of the site contains information about medicines, their properties, methods of use, as well as other specialized information that is intended for healthcare professionals. The information on medicines contained in this section is not a guide for self-diagnosis and / or treatment. LLC SA Pro-Pharma is not responsible for possible negative consequences arising from the independent use of information from this section. Using the information from this section, you do it yourself, understanding that: self-medication can be harmful to your health, you must read the instructions and consult a doctor before using medicines.